Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.

GLP-1 patches do not contain any pharmaceutical ingredient from semaglutide or tirzepatide

GLP-1 drugs, which have helped some people curb drug and alcohol use, may unlock a pathway to moderation.

Por Ayushi Shah, CNNEn cualquier mañana en el parque Shivaji de Mumbai, los caminantes rápidos recorren la pista de atletismo, con reloje...

Our community shared deeply mixed experiences of Ozempic and Mounjaro, with many warning of severe and sometimes debilitating side effects,...

Weight loss now comes with a silent asterisk. When bodies change quickly or noticeably, assumptions often follow—and so does the desire to a...

With a hungry ghost and a series of crippling self-esteem issues in tow, Saccharine leaves a lot for audiences to stomach. Six years after m...

Gen-Z fitness fanatics are injecting themselves with experimental drugs sold illegally online in a craze fuelled by influencers, a Mail inve...

Low energy. “Ozempic face.” Feeling like a deflated balloon.They can be the downsides for people on GLP-1s, the increasingly popular drugs...

Novo Nordisk is worried about competition and wants to be seen as the cool kid... by using a 20-year-old ad format.

Meet Elcella - the buzzy new supplement people are calling the 'natural Mounjaro'. It promises to tame your appetite by coaxing your gut to...

Michal Berkner is said to be a powerful driver of his political career, with former Conservative colleagues describing her as a 'force of na...

A former nurse in Chicago has been charged in federal court with distributing counterfeit Ozempic weight-loss drugs.Sharon Sackman, a re...

Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high prices

Former Dancing With the Stars troupe member Stephani Sosa has shared her history with controversial weight loss medication Ozempic.“People...